SRES-140-119
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S1864; text: CR S1875)
Sponsored by Jeff Merkley (D-OR)
What it does
This resolution designates the first week of April 2025 as "National Asbestos Awareness Week." It is a symbolic measure passed by the Senate that carries no legal mandates, no funding, and no regulatory requirements. Resolutions of this type express the sense of the Senate and place a named observance on the calendar.
Who benefits
Advocacy organizations focused on asbestos-related diseases (such as mesothelioma and asbestosis) may benefit from increased public visibility. Patients diagnosed with asbestos-related illnesses, their families, and medical researchers in this field may benefit from any awareness-raising effect. Public health communicators would have an official platform to disseminate information during the designated week.
Who is hurt
No group is directly or materially harmed by this resolution. It imposes no costs, restrictions, or obligations on any individual, business, or government entity.
Supporters argue
Supporters argue that asbestos-related diseases — including mesothelioma, asbestosis, and lung cancer — kill thousands of Americans each year, often decades after exposure, and that many people remain unaware of ongoing risks from asbestos in older buildings, products, and worksites. They contend that a nationally recognized awareness week gives public health organizations, medical professionals, and patient advocates a coordinated moment to educate the public, encourage early screening, and push for stronger protections. Supporters also note that the resolution passed by unanimous consent, reflecting broad bipartisan agreement that raising awareness of a preventable disease carries no meaningful downside.
Opponents argue
Opponents, or skeptics, argue that symbolic resolutions like this one consume limited legislative time and floor resources without producing measurable public health outcomes. They contend that if Congress is serious about addressing asbestos-related illness, it should pass binding legislation — such as a comprehensive asbestos ban or increased funding for research and treatment — rather than a non-binding designation that carries no enforcement mechanism, no appropriation, and no accountability for results. From this view, awareness weeks risk substituting the appearance of action for substantive policy change.